CTCA Hospitals Enrolling Myeloma, Other Cancer Patients, in TAPUR Clinical Trial
Cancer Treatment Centers of America (CTCA) recently began enrolling…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
Triple-Combo Treatment of Smoldering Multiple Myeloma May Stall Disease Progression
Early treatment with a combination of anti-cancer drugs in…
Specialty US Pharmacy, Diplomat, to Dispense Darzalex Combo to Advanced Myeloma Patients
The monoclonal antibody Darxalex (daratumumab) was recently approved by…
Aduro Presents Positive Results on BION-1301 for Treating Multiple Myeloma
Aduro Biotech recently presented positive preclinical data showing that…
2 Common Additions to Multiple Myeloma Therapy Don’t Offer Added Benefit, Study Says
The results of a new clinical trial suggest that…
Bluebird’s CAR T-cell Therapy Shows Promise in Advanced Multiple Myeloma Patients
Patients with advanced multiple myeloma may benefit from bluebird…
